EndoClot Plus Overview
- Year Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
EndoClot Plus General Information
Description
Manufacturer of medical devices designed for gastrointestinal bleeding control. The company's technology utilizes absorbable modified polymer particles and controlled air pressure delivery to accelerate natural clotting, providing healthcare providers with polysaccharide hemostatic systems, adhesive hemostatic polymers, submucosal injection systems, portable air compressors, and hemostatic powder applicators to stop bleeding rapidly during endoscopic procedures.
Contact Information
Website
www.endoclot.comCorporate Office
- 101st Floor, Building B8, BioNano Park
- Number 218 Xinghu Street Suzhou Industrial Park Suzhou Area of China Pilot Free Trade Zone
- Suzhou, Jiangsu 215123
- China
Corporate Office
- 101st Floor, Building B8, BioNano Park
- Number 218 Xinghu Street Suzhou Industrial Park Suzhou Area of China Pilot Free Trade Zone
- Suzhou, Jiangsu 215123
- China
EndoClot Plus Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Secondary Transaction - Private | 29-Oct-2025 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | 27-Jan-2025 | Completed | Generating Revenue | |||
| 3. Secondary Transaction - Private | 24-Dec-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 26-Oct-2018 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 25-Aug-2016 | Completed | Startup |
EndoClot Plus Patents
EndoClot Plus Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20110178495-A1 | Internal dry powder delivery system and method thereof | Active | 15-Jan-2010 | ||
| US-20130046278-A1 | Internal dry powder delivery system and method thereof | Active | 15-Jan-2010 | ||
| US-20140207097-A1 | Internal dry powder delivery system and method thereof | Active | 15-Jan-2010 | ||
| US-8827980-B2 | Internal dry powder delivery system and method thereof | Active | 15-Jan-2010 | ||
| US-9205207-B2 | Internal dry powder delivery system and method thereof | Active | 15-Jan-2010 | A61M13/00 |
EndoClot Plus Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| LYFE Capital | PE/Buyout | Minority |
EndoClot Plus FAQs
-
When was EndoClot Plus founded?
EndoClot Plus was founded in 2014.
-
Where is EndoClot Plus headquartered?
EndoClot Plus is headquartered in Suzhou, China.
-
What industry is EndoClot Plus in?
EndoClot Plus’s primary industry is Medical Supplies.
-
Is EndoClot Plus a private or public company?
EndoClot Plus is a Private company.
-
What is EndoClot Plus’s current revenue?
The current revenue for EndoClot Plus is .
-
Who are EndoClot Plus’s investors?
LYFE Capital has invested in EndoClot Plus.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process